z-logo
open-access-imgOpen Access
Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer
Author(s) -
Marzia Locatelli,
Philippe Aftimos,
Claire Dees,
Patricia LoRusso,
Mark D. Pegram,
Ahmad Awada,
Bo Huang,
Rossano Cesari,
Yuqiu Jiang,
M. Naveed Shaik,
Kenneth A. Kern,
Giuseppe Curigliano
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/nc45-a394
Subject(s) - docetaxel , triple negative breast cancer , oncology , medicine , cancer , breast cancer , cancer research , triple negative

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom